MedTrace Logo

Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis

NCT06546033 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-08-09

No results posted yet for this study

Summary

When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.

Conditions

Interventions

OTHER

application of different types of diet

application of different types of diet

Sponsors & Collaborators

  • Acibadem University

    collaborator OTHER

  • Nigde Omer Halisdemir University

    lead OTHER

Principal Investigators

  • Nihan Çakır Biçer, PhD. · Acıbadem Mehmet Ali Aydınlar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-02
Primary Completion
2026-09-02
Completion
2026-12-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546033 on ClinicalTrials.gov